Naomi Holman

4.2k total citations · 2 hit papers
39 papers, 2.4k citations indexed

About

Naomi Holman is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Genetics. According to data from OpenAlex, Naomi Holman has authored 39 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Epidemiology and 8 papers in Genetics. Recurrent topics in Naomi Holman's work include Chronic Disease Management Strategies (14 papers), Diabetes Management and Research (12 papers) and Diabetes Management and Education (11 papers). Naomi Holman is often cited by papers focused on Chronic Disease Management Strategies (14 papers), Diabetes Management and Research (12 papers) and Diabetes Management and Education (11 papers). Naomi Holman collaborates with scholars based in United Kingdom, United States and Ireland. Naomi Holman's co-authors include Bob Young, Jonathan Valabhji, Kamlesh Khunti, Naveed Sattar, Peter Knighton, Chirag Bakhai, Emma Barron, Partha Kar, Nicholas J. Wareham and William Jeffcoate and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Diabetologia.

In The Last Decade

Naomi Holman

36 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study

2020 639 citations Emma Barron, Chirag Bakhai et al. The Lancet Diabetes & Endocrinology profile →
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study

2020 600 citations Naomi Holman, Peter Knighton et al. The Lancet Diabetes & Endocrinology profile →

Peers

Countries citing papers authored by Naomi Holman

Since Specialization

Citations

This map shows the geographic impact of Naomi Holman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi Holman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi Holman more than expected).

Fields of papers citing papers by Naomi Holman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naomi Holman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi Holman. The network helps show where Naomi Holman may publish in the future.

Co-authorship network of co-authors of Naomi Holman

This figure shows the co-authorship network connecting the top 25 collaborators of Naomi Holman. A scholar is included among the top collaborators of Naomi Holman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naomi Holman. Naomi Holman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multiple long-term conditions as the next transition in the global diabetes epidemic 2025 ·Communications Medicine ·Edward W. Gregg, Naomi Holman, Marisa K. Sophiea, Shivani Misra, Jonathan Pearson‐Stuttard, Jonathan Valabhji, Kamlesh Khunti	4
2	Trends in mortality and hospitalisations for cardiovascular, kidney and liver disease in people with type 2 diabetes in England, 2009–2019 2025 ·Diabetes Obesity and Metabolism ·Naomi Holman, Bob Young, Edward W. Gregg, Nicholas J. Wareham, Stephen J. Sharp, Kamlesh Khunti, Naveed Sattar, Jonathan Valabhji	0
3	Socioeconomic disparities in diabetes prevalence among the population in Ireland 2025 ·BMC Public Health ·(unknown), Naomi Holman, Steven James, Nick Clarke, (unknown), Kathleen Bennett, Jan Sørensen, Edward W. Gregg	0
4	Mortality rates in people presenting with a new diabetes-related foot ulcer: a cohort study with implications for management 2024 ·Diabetologia ·Naomi Holman, (unknown), Bob Young, Jonathan Valabhji, William Jeffcoate, Frances L. Game	7
5	Can the introduction of a 12-lead ECG help reduce mortality in those presenting with foot ulceration to multidisciplinary diabetic foot clinics? An observational evaluation of a real-world implementation pilot in England 2024 ·Diabetologia ·Jonathan Valabhji, Naomi Holman, Nicholas Collins, Bob Young, Paul Chadwick, (unknown), (unknown), Satyan Rajbhandari, (unknown), Marie‐France Kong, Simon Ashwell, (unknown), Sanjeev N. Mehta, Chris Manu, Michael Edmonds, Catherine Gooday, Ketan Dhatariya	1
6	Trends in all-cause and cause-specific mortality by BMI levels in England, 2004–2019: a population-based primary care records study 2024 ·The Lancet Regional Health - Europe ·(unknown), Francesco Zaccardi, Yiling J. Cheng, Eszter P. Vamos, Naomi Holman, Edward W. Gregg	5
7	Trends in hospitalization for cardio‐renal disease and mortality in people with type 1 diabetes in England, 2009–2019 2024 ·Diabetes Obesity and Metabolism ·Naomi Holman, Bob Young, Edward W. Gregg, Nicholas J. Wareham, Stephen J. Sharp, Kamlesh Khunti, Naveed Sattar, Jonathan Valabhji	3
8	Improving risk prediction model quality in the critically ill: data linkage study 2022 ·SHILAP Revista de lepidopterología ·Paloma Ferrando-Vivas, Manu Shankar‐Hari, Karen Thomas, James Doidge, Fergus Caskey, Lui G. Forni, Steve Harris, Marlies Ostermann, Ivan Gornik, Naomi Holman, Nazir Lone, Bob Young, David P. Jenkins, Stephen Webb, Jerry P. Nolan, Jasmeet Soar, Kathy Rowan, David A Harrison	1
9	Incidence and Characteristics of Remission of Type 2 Diabetes in England: A Cohort Study Using the National Diabetes Audit 2022 ·Diabetes Care ·Naomi Holman, Sarah H. Wild, Kamlesh Khunti, Peter Knighton, (unknown), Chirag Bakhai, Bob Young, Naveed Sattar, Jonathan Valabhji, Edward W. Gregg	32
10	Associations between reductions in routine care delivery and non-COVID-19-related mortality in people with diabetes in England during the COVID-19 pandemic: a population-based parallel cohort study 2022 ·The Lancet Diabetes & Endocrinology ·Jonathan Valabhji, Emma Barron, Tessa Gorton, Chirag Bakhai, Partha Kar, Bob Young, Kamlesh Khunti, Naomi Holman, Naveed Sattar, Nicholas J. Wareham	32
11	Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England 2021 ·The Lancet Diabetes & Endocrinology ·Kamlesh Khunti, Peter Knighton, Francesco Zaccardi, Chirag Bakhai, Emma Barron, Naomi Holman, Partha Kar, (unknown), Naveed Sattar, Stephen J. Sharp, Nicholas J. Wareham, (unknown), (unknown), Bob Young, Jonathan Valabhji	123
12	Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study breakdown → 2020 ·The Lancet Diabetes & Endocrinology ·Emma Barron, Chirag Bakhai, Partha Kar, (unknown), Dominique Bradley, Hassan Ismail, Peter Knighton, Naomi Holman, Kamlesh Khunti, Naveed Sattar, Nicholas J. Wareham, Bob Young, Jonathan Valabhji	639
13	Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study breakdown → 2020 ·The Lancet Diabetes & Endocrinology ·Naomi Holman, Peter Knighton, Partha Kar, (unknown), (unknown), (unknown), Emma Barron, Chirag Bakhai, Kamlesh Khunti, Nicholas J. Wareham, Naveed Sattar, Bob Young, Jonathan Valabhji	600
14	Prevalence of Celiac Disease in 52,721 Youth With Type 1 Diabetes: International Comparison Across Three Continents 2017 ·Diabetes Care ·Maria E. Craig, (unknown), Claire T. Boyle, Fiona Campbell, Timothy W. Jones, Sabine Hofer, Jill H. Simmons, Naomi Holman, Elaine Tham, Elke Fröhlich‐Reiterer, Stephanie N. DuBose, Helen Thornton, Bruce R. King, David M. Maahs, Reinhard W. Holl, Justin Warner, (unknown), (unknown)	92
15	Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries 2015 ·Diabetologia ·Jennifer L. Sherr, Julia M. Hermann, Fiona Campbell, Nicole C. Foster, Sabine E. Hofer, Jeremy Allgrove, David M. Maahs, Thomas Kapellen, Naomi Holman, William V. Tamborlane, Reinhard W. Holl, Roy W. Beck, Justin Warner	178
16	Women with pre‐gestational diabetes have a higher risk of stillbirth at all gestations after 32 weeks 2014 ·Diabetic Medicine ·Naomi Holman, Ruth Bell, Helen Murphy, M. Maresh	18
17	Variation in the recorded incidence of amputation of the lower limb in England 2012 ·Diabetologia ·Naomi Holman, Robert J. Young, William Jeffcoate	158
18	Development and evaluation of a standardized registry for diabetes in pregnancy using data from the Northern, North West and East Anglia regional audits¹ 2011 ·Diabetic Medicine ·Naomi Holman, Nick Lewis‐Barned, Ruth Bell, (unknown), Jo Modder, Jason Gardosi, Anne Dornhorst, Rowan Hillson, Bob Young, Helen Murphy, (unknown)	19
19	Using data to inform care needs planning for people with diabetes 2011 ·Practice Nursing ·Naomi Holman, Anne Phillips	1
20	The Association of Public Health Observatories (APHO) Diabetes Prevalence Model: estimates of total diabetes prevalence for England, 2010–2030 2010 ·Diabetic Medicine ·Naomi Holman, Nita G. Forouhi, Elizabeth Goyder, Sarah H. Wild	108

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact